SPRC Latest Press Releases

-- October 15, 2026 --

SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies Globe Newswire 7:06 AM

-- October 7, 2026 --

SciSparc: Subsidiary NeuroThera Labs' CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company's Quantum Architecture Globe Newswire 8:22 AM

-- September 23, 2026 --

SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations Globe Newswire 8:35 AM

-- September 2, 2026 --

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies Globe Newswire 8:17 AM

-- August 31, 2026 --

SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI-210 Autism Clinical Trial Globe Newswire 4:03 PM

-- August 26, 2026 --

SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board Globe Newswire 8:32 AM

-- August 24, 2026 --

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation Globe Newswire 8:51 AM

-- August 18, 2026 --

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc's Stake Valued at Approximately C$30 Million Globe Newswire 8:06 AM

-- August 12, 2026 --

SciSparc's Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination Globe Newswire 8:25 AM

-- August 5, 2026 --

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome Globe Newswire 8:22 AM

-- July 31, 2026 --

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics Globe Newswire 8:20 AM

-- July 29, 2026 --

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company Globe Newswire 8:32 AM

-- July 27, 2026 --

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity Globe Newswire 8:25 AM

-- July 15, 2026 --

SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome Globe Newswire 8:41 AM

-- June 4, 2026 --

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum Globe Newswire 7:32 AM

-- May 28, 2026 --

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum Globe Newswire 8:40 AM

Market Data Delayed 15 Minutes